Compare ONCY & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONCY | STHO |
|---|---|---|
| Founded | 1998 | 2022 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.1M | 118.3M |
| IPO Year | 2002 | 2022 |
| Metric | ONCY | STHO |
|---|---|---|
| Price | $0.89 | $9.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 596.3K | 17.1K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.73 |
| EPS | N/A | ★ 2.58 |
| Revenue | N/A | ★ $110,143,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,505.00 | N/A |
| P/E Ratio | ★ N/A | $3.73 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.73 | $7.08 |
| 52 Week High | $1.51 | $9.94 |
| Indicator | ONCY | STHO |
|---|---|---|
| Relative Strength Index (RSI) | 57.13 | 51.81 |
| Support Level | $0.85 | $8.71 |
| Resistance Level | $1.08 | $9.76 |
| Average True Range (ATR) | 0.04 | 0.28 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 100.00 | 66.31 |
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties, and land and development properties.